| Literature DB >> 31853243 |
Ana Maria Carbajo-García1, Jonatan Cortés1, Adrià Arboix1, Joan Massons1, Laura Díez1, Enric Vergés1, Jordi Arboix-Alió2, Luís García-Eroles3.
Abstract
OBJECTIVE: To assess predictive clinical factors of cardioembolic infarction in very old patients (85 years of age and older).Entities:
Keywords: Cardioembolic stroke; Clinical features; Ischemic infarction; Stroke; Very old patients
Year: 2019 PMID: 31853243 PMCID: PMC6911804 DOI: 10.11909/j.issn.1671-5411.2019.11.008
Source DB: PubMed Journal: J Geriatr Cardiol ISSN: 1671-5411 Impact factor: 3.327
Results of univariate analysis: differences between patients with cardioembolic infarction according to age.
| Age ≥ 85 yrs ( | Age < 85 yrs ( | |||||
| Demographics | ||||||
| Male patients | 90 (28.4%) | 264 (41.3%) | 0.001 | |||
| Female patients | 227 (71.6%) | 374 (58.5%) | ||||
| Age, yrs | 88.9 ± 3.3 | 75.5 ± 7.7 | 0.001 | |||
| Risk factors | ||||||
| Hypertension | 154 (48.6%) | 358 (56.0%) | 0.018 | |||
| Diabetes mellitus | 52 (16.4%) | 125 (19.6%) | 0.136 | |||
| Valve heart disease | 30 (9.5%) | 126 (19.7%) | 0.001 | |||
| Ischemic heart disease | 60 (18.9%) | 139 (21.8%) | 0.177 | |||
| Atrial fibrillation | 246 (77.6%) | 464 (72.6%) | 0.056 | |||
| Congestive heart failure | 51 (16.1%) | 49 (7.7%) | 0.001 | |||
| History of TIA | 37 (11.7%) | 59 (9.2%) | 0.143 | |||
| History of cerebrovascular disease | 56 (17.7%) | 118 (18.5%) | 0.418 | |||
| Previous cerebral hematoma | 4 (1.3%) | 7 (1.1%) | 0.523 | |||
| COPD | 28 (8.8%) | 56 (8.8%) | 0.530 | |||
| Chronic renal disease | 23 (7.3%) | 34 (5.3%) | 0.148 | |||
| Peripheral vascular disease | 16 (5.0%) | 52 (8.1%) | 0.05 | |||
| Chronic liver disease | 5 (1.6%) | 10 (4.8%) | 0.001 | |||
| Hyperlipidemia | 32 (10.1%) | 98 (15.3%) | 0.015 | |||
| Heavy smoking (> 20 cigarettes/day) | 3 (0.9%) | 39 (6.1%) | 0.001 | |||
| Clinical features | ||||||
| Sudden onset | 195 (61.5%) | 429 (67.1%) | 0.050 | |||
| Headache | 11 (3.5%) | 62 (9.7%) | 0.001 | |||
| Vegetative symptoms | 11 (2.5%) | 36 (17.1%) | 0.001 | |||
| Early seizures | 2 (0.8%) | 15 (2.3%) | 0.044 | |||
| Nausea/vomiting | 16 (5.0%) | 46 (7.2%) | 0.128 | |||
| Altered consciousness | 118 (37.2%) | 146 (22.8%) | 0.001 | |||
| Motor symptoms | 261 (82.3%) | 500 (78.2%) | 0.081 | |||
| Sensory symptoms | 103 (32.5%) | 242 (37.9%) | 0.059 | |||
| Visual disturbances | 62 (19.6%) | 140 (21.9%) | 0.226 | |||
| Speech disturbances | 192 (60.6%) | 396 (62.0%) | 0.363 | |||
| Ataxia | 12 (3.8%) | 28 (4.4%) | 0.403 | |||
| Cranial nerve palsy | 13 (4.1%) | 30 (4.7%) | 0.407 | |||
| Vascular topography | ||||||
| Middle cerebral artery involvement | 209 (65.9%) | 411 (64.3%) | 0.623 | |||
| Posterior cerebral artery involvement | 15 (4.7%) | 62 (9.7%) | 0.212 | |||
| Anterior choroidal artery | 3 (0.9%) | 1 (0.2%) | 0.495 | |||
| Vertebral artery | 3 (0.9%) | 16 (2.5%) | 0.168 | |||
| Basilar artery | 6 (1.9%) | 17 (2.7%) | 0.466 | |||
| Posteroinferior cerebellar artery | 2 (0.6%) | 7 (1.1%) | 0.730 | |||
| Superior cerebellar artery | 3 (0.9%) | 5 (0.8%) | 1.000 | |||
| Complications | ||||||
| Neurological | 41 (12.9%) | 85 (13.3%) | 0.481 | |||
| Respiratory | 68 (21.5%) | 70 (11.0%) | 0.001 | |||
| Renal | 4 (0.9%) | 6 (3.8%) | 0.01 | |||
| Urinary | 36 (11.4%) | 50 (7.8%) | 0.048 | |||
| Cardiac events | 30 (9.5%) | 56 (8.8%) | 0.403 | |||
| Vascular | 9 (2.8%) | 18 (2.8%) | 0.566 | |||
| Infectious | 81 (25.6%) | 91 (14.2%) | 0.001 | |||
| Outcome | ||||||
| At hospital discharge | ||||||
| Symptom free | 32 (10.1%) | 91 (14.2%) | 0.043 | |||
| Degree of disability/dependence, mRS | ||||||
| 0–1, no symptoms, no significant disability | 41 (12.9%) | 127 (19.9%) | 0.005 | |||
| 2, slight disability | 48 (15.1%) | 154 (24.1%) | 0.001 | |||
| 3, moderate disability | 50 (15.8%) | 118 (18.5%) | 0.174 | |||
| 4 or 5, severe neurological impairment | 54 (17.0%) | 81 (17.7%) | 0.044 | |||
| Length hospital stay, days, median (IQR) | 14 (10–24) | 13 (8–22) | 0.013 | |||
| In-hospital mortality | 97 (30.6%) | 121 (18.9%) | 0.001 | |||
Data are presented as mean ± SD or n (%). COPD: chronic obstructive pulmonary disease; IQR: interquartile range; mRS: modified Rankin Scale; TIA: transient ischemic attack.
Results of multivariate analysis: variables independently associated with cardioembolic infarction in subjects aged 85 years or older.
| Regression models | Coefficient (β) | Standard error | Odds ratio (95% confidence interval) | |
| Model 1: demographics and risk factors | ||||
| Congestive heart failure | 0.816 | 0.221 | 2.26 (1.47–3.48) | 0.001 |
| Female gender | 0.559 | 0.156 | 1.75 (1.29–2.37) | 0.001 |
| Hypertension | –0.428 | 0.144 | 0.65 (0.49–0.86) | 0.003 |
| Valve heart disease | –1.042 | 0.223 | 0.35 (0.23–0.55) | 0.001 |
| Smoking | –1.703 | 0.613 | 0.18 (0.06–0.60) | 0.005 |
| Model 2: demographics, risk factors, clinical features and vascular topography | ||||
| Congestive heart failure | 0.827 | 0.227 | 2.29 (1.47–3.56) | 0.001 |
| Altered consciousness | 0.645 | 0.161 | 1.90 (1.39–2.61) | 0.001 |
| Female gender | 0.554 | 0.160 | 1.74 (1.27–2.38) | 0.001 |
| Sensory deficit | –0.367 | 0.157 | 0.69 (0.51–0.94) | 0.019 |
| Hypertension | –0.376 | 0.148 | 0.69 (0.51–0.92) | 0.011 |
| Posterior cerebral artery | –0.702 | 0.317 | 0.50 (0.27–0.92) | 0.027 |
| Valve heart disease | –0.959 | 0.227 | 0.38 (0.25–0.60) | 0.001 |
| Headache | –1.014 | 0.347 | 0.36 (0.18–0.72) | 0.003 |
| Early seizures | –1.629 | 0.793 | 0.20 (0.04–0.93) | 0.040 |
| Smoking | –1.676 | 0.622 | 0.19 (0.05–0.63) | 0.007 |
| Model 3: demographics, risk factors, clinical features, vascular topography and complications | ||||
| Congestive heart failure | 0.822 | 0.228 | 2.27 (1.46–3.56) | 0.001 |
| Infectious complications | 0.700 | 0.188 | 2.01 (1.39–2.91) | 0.001 |
| Altered consciousness | 0.566 | 0.163 | 1.76 (1.28–2.42) | 0.001 |
| Female gender | 0.552 | 0.161 | 1.74 (1.27–2.38) | 0.001 |
| Hypertension | –0.370 | 0.149 | 0.69 (0.52–0.93) | 0.013 |
| Sensory deficit | –0.468 | 0.161 | 0.63 (0.46–0.86) | 0.004 |
| Posterior cerebral artery | –0.671 | 0.319 | 0.51 (0.27–0.95) | 0.035 |
| Valve heart disease | –0.957 | 0.229 | 0.38 (0.24–0.60) | 0.001 |
| Headache | –1.004 | 0.348 | 0.37 (0.18–0.72) | 0.004 |
| Early seizures | –1.686 | 0.791 | 0.18 (0.04–0.87) | 0.033 |
| Smoking | –1.734 | 0.634 | 0.18 (0.05–0.61) | 0.006 |
Model 1: Hosmer-Lemeshow goodness-of-fit test 0.999, subjects ≥ 85 years versus < 85 years were correctly classified in 58% of cases; Model 2: Hosmer-Lemeshow goodness-of-fit test 0.210, subjects ≥ 85 years versus < 85 years were correctly classified in 66% of cases; Model 3: Hosmer-Lemeshow goodness-of-fit test 0.064, subjects ≥ 85 years versus < 85 years were correctly classified in 66% of cases.
Figure 1.ROC curve for regression model 3 including demographics, cardiovascular risk factors, clinical features, vascular topography and complications (AUC: 0.715).
AUC: area under the curve; ROC: receiver operating characteristics.